Liraglutide's efficacy as insulin add-on for Type 1 Diabetes investigated in randomized trial.
Liraglutide in Type 1 Diabetes
Abstract
A randomized, double-blind, placebo-controlled trial is investigating liraglutide 1.8 mg daily as an add-on to insulin for poorly regulated Type 1 Diabetes patients.